Tevogen Bio Holdings宣布其新业务线预计将带来显著财务贡献,年收入有望增加超过2000万美元。这一增长动力预计将从明年开始,持续推动公司实现两位数的高增速扩张。
Tevogen Bio Holdings宣布其新业务线预计将带来显著财务贡献,年收入有望增加超过2000万美元。这一增长动力预计将从明年开始,持续推动公司实现两位数的高增速扩张。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.